个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Zhou, Caicun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] * ; Huang, Yunchao[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; An, Changshan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Wang, Donglin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; He, Jianxing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Zhou, Fuxiang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Chen, Gongyan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Li, Yali[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Wu, Changping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Wu, Gang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Song, Xia[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Gao, Jianfei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Liu, Wei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Li, Baolan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Shi, Jianhua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Huang, Cheng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Yu, Ping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Feng, Jueping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Liu, Yi[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ; Xia, Jielai[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22] ;
机构： [1]Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China [2]Kunming Med Univ, Affiliated Hosp 3, Yunnan Tumor Hosp, Kunming, Peoples R China [3]Yanbian Univ Hosp, Yanji, Peoples R China [4]Chongqing Canc Hosp, Chongqing, Peoples R China [5]Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Guangzhou, Guangdong, Peoples R China [6]Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China [7]China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China [8]Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China [9]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [10]Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710049, Peoples R China [11]Soochow Univ, Affiliated Hosp 3, Dept Oncol, Changzhou, Peoples R China [12]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China [13]Shanxi Prov Tumor Hosp, Taiyuan, Peoples R China [14]PLA Guangzhou Mil Reg, Wuhan Gen Hosp, Wuhan, Peoples R China [15]Hebei Tumor Hosp, Shijiazhuang, Peoples R China [16]Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China [17]Linyi Tumor Hosp, Linyi, Peoples R China [18]Canc Hosp Fujian, Fuzhou, Peoples R China [19]Sichuan Canc Hosp, Dept Lung Canc Med Oncol, Chengdu, Peoples R China [20]Wuhan Puai Hosp, Wuhan, Peoples R China [21]Jiangsu Hengrui Med Co, Lianyungang, Peoples R China [22]Fourth Mil Med Univ, Xian 710032, Peoples R China
出处：
DOI： 10.1200/jco.2014.32.15_suppl.9614
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2014]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2014]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者：
第一作者机构： [1]Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China [2]Kunming Med Univ, Affiliated Hosp 3, Yunnan Tumor Hosp, Kunming, Peoples R China [3]Yanbian Univ Hosp, Yanji, Peoples R China [4]Chongqing Canc Hosp, Chongqing, Peoples R China [5]Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Guangzhou, Guangdong, Peoples R China [6]Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China [7]China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China [8]Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China [9]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [10]Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710049, Peoples R China [11]Soochow Univ, Affiliated Hosp 3, Dept Oncol, Changzhou, Peoples R China [12]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China [13]Shanxi Prov Tumor Hosp, Taiyuan, Peoples R China [14]PLA Guangzhou Mil Reg, Wuhan Gen Hosp, Wuhan, Peoples R China [15]Hebei Tumor Hosp, Shijiazhuang, Peoples R China [16]Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China [17]Linyi Tumor Hosp, Linyi, Peoples R China [18]Canc Hosp Fujian, Fuzhou, Peoples R China [19]Sichuan Canc Hosp, Dept Lung Canc Med Oncol, Chengdu, Peoples R China [20]Wuhan Puai Hosp, Wuhan, Peoples R China [21]Jiangsu Hengrui Med Co, Lianyungang, Peoples R China [22]Fourth Mil Med Univ, Xian 710032, Peoples R China
推荐引用方式(GB/T 7714)：
Zhou Caicun,Huang Yunchao,An Changshan,et al.Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy[J].JOURNAL OF CLINICAL ONCOLOGY.2014,32(15):doi:10.1200/jco.2014.32.15_suppl.9614.
APA：
Zhou, Caicun,Huang, Yunchao,An, Changshan,Wang, Donglin,He, Jianxing...&Xia, Jielai.(2014).Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy.JOURNAL OF CLINICAL ONCOLOGY,32,(15)
MLA：
Zhou, Caicun,et al."Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy".JOURNAL OF CLINICAL ONCOLOGY 32..15(2014)

资源点击量：52808 今日访问量：0 总访问量：4561 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号